These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6397595)

  • 1. Inhibition of human NK cell cytotoxicity against K562 cells with glycopeptides from K562 plasma membranes.
    Decker JM; Hinson A; Ades EW
    J Clin Lab Immunol; 1984 Nov; 15(3):137-43. PubMed ID: 6397595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of inhibition of natural killing by a glycopeptide isolated from the K562 plasma membrane.
    Targan S; Decker JM; Ades EW
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):113-23. PubMed ID: 6438498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanism.
    Brahmi Z; Bray RA; Abrams SI
    J Immunol; 1985 Dec; 135(6):4108-13. PubMed ID: 3864859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
    Roozemond RC; Bonavida B
    J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target cell directed NK inactivation. Concomitant loss of NK and antibody-dependent cellular cytotoxicity activities.
    Abrams SI; Brahmi Z
    J Immunol; 1988 Mar; 140(6):2090-5. PubMed ID: 3279127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
    Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
    J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evidence against a role for toxic oxygen products as lytic agents in NK cell-mediated cytotoxicity.
    Van Kessel KP; Van Strijp JA; Van Kats-Renaud HJ; Miltenburg LA; Van Der Tol ME; Fluit AC; Verhoef J
    Immunology; 1987 Dec; 62(4):675-8. PubMed ID: 3480874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethanol and natural killer cells. II. Stimulation of human natural killer activity by ethanol in vitro.
    Li F; Cook RT; Alber C; Rasmussen W; Stapleton JT; Ballas ZK
    Alcohol Clin Exp Res; 1997 Sep; 21(6):981-7. PubMed ID: 9309305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemiluminescence response of human natural killer cells. II. Association of a decreased response with low natural killer activity.
    Werkmeister J; Helfand S; Roder J; Pross H
    Eur J Immunol; 1983 Jun; 13(6):514-20. PubMed ID: 6574914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
    Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
    Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of target antigens specifically recognized by human natural killer cells.
    Henkart PA; Lewis JT; Ortaldo JR
    Nat Immun Cell Growth Regul; 1986; 5(3):113-26. PubMed ID: 2426585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
    Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
    Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compared mechanisms of tumor cytolysis by human natural killer cells and activated polymorphonuclear leukocytes.
    Abrams SI; Brahmi Z
    J Immunol; 1984 Jun; 132(6):3192-6. PubMed ID: 6327820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of mouse natural killer activity by cyclosporin A.
    Yanagihara RH; Adler WH
    Immunology; 1982 Feb; 45(2):325-32. PubMed ID: 6460686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF; Triglia T; Werkmeister JA
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
    Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER
    Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lytic activity of IL-2 and IL-12 stimulated NK cells against HOS osteosarcoma cell line.
    Mariani E; Tarozzi A; Meneghetti A; Tadolini M; Facchini A
    Boll Soc Ital Biol Sper; 1996; 72(1-2):21-7. PubMed ID: 8868111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas involvement in cytotoxicity mediated by human NK cells.
    Montel AH; Bochan MR; Hobbs JA; Lynch DH; Brahmi Z
    Cell Immunol; 1995 Dec; 166(2):236-46. PubMed ID: 7497525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of novel eicosanoids lipoxin A and B on human natural killer cell cytotoxicity: effects on intracellular cAMP and target cell binding.
    Ramstedt U; Ng J; Wigzell H; Serhan CN; Samuelsson B
    J Immunol; 1985 Nov; 135(5):3434-8. PubMed ID: 2995494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.